Osteoporosis management in patients with breast cancer: EMAS position statement-Reference-Cited by-同舟云学术

Osteoporosis management in patients with breast cancer: EMAS position statement

Published:2017-01 Issue: Volume:95 Page:65-71
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Trémollieres Florence A.,Ceausu Iuliana,Depypere Herman,Lambrinoudaki Irene,Mueck Alfred,Pérez-López Faustino R.,van der Schouw Yvonne T.,Senturk Levent M.,Simoncini Tommaso,Stevenson John C.,Stute Petra,Rees Margaret

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,General Biochemistry, Genetics and Molecular Biology

Reference53 articles.

1. NCCN guidelines update: breast cancer;Gradishar;J. Natl. Compr. Canc. Netw.,2016

2. Effect of an aromatase inhibitor on BMD and bone turnover markers: 2-year results of the anastrozole, tamoxifen, alone or in combination (ATAC) trial (18233230);Eastell;J. Bone Miner. Res.,2006

3. Skeletal effects of exemestane on bone mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the intergroup exemestane study (IES): a randomised controlled study;Coleman;Lancet Oncol.,2007

4. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17;Goss;J. Natl. Cancer Inst.,2005

5. Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane;Gonnelli;Bone,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention and Co-Management of Breast Cancer-Related Osteoporosis Using Resveratrol;Nutrients;2024-02-29

2. DXA assessment and fracture prevention in hormone positive breast cancer patients after treatment initiation with aromatase inhibitors: A registry-based cohort study;Journal of Bone Oncology;2023-10

3. Treatment of women with BRCA mutation;Climacteric;2023-04-03

4. Honey: A Promising Therapeutic Supplement for the Prevention and Management of Osteoporosis and Breast Cancer;Antioxidants;2023-02-24

5. Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians;Annals of Internal Medicine;2023-02